Insulin Regimen in Adults With Type-1 Diabetes in the Middle East: Results From the International Diabetes Management Practices Survey (IDMPS).

RAMACHANDRAN A; GAGLIARDINO JJ ET AL

Philadelpia

Congreso; American Diabetes Association’s 72nd Scientific Sessions; 2012

American Diabetes Association

IDMPS is an ongoing 5-y multinational observational study documenting the current quality of care provided to people with type 1 or type 2 diabetes. Feasibility analyses were previously performed to validate the chances of pooling the data collected during 3 y in the Middle East. The aim was to identify patient profiles associated with insulin regimen in type 1 diabetes mellitus (TlDM) patients in the Middle East. Patient profiles of 1316 patients were determined using logistic regression analysis. The most common insulin regimen was basal-prandial therapy (51.1%1. followed by premix (29.9%), basal therapy alone (10.4%), and other regimens (8.7%). The mea n duration of the basal-prandial therapy treatment was 10.9 ± 8.5 y. In patients treated with the basal-prandial regimen, 54.9% used vials and syringes and 51.6% used insulin pens. The number of insulin injections/day was 3.9 ± 0.7, and 95.4% received 3 to 6 injections/d. Basal and prandial daily doses were 0.47 ± 0.23 and 0.37 ± 0.27 IU/kg respectively. Of the patients on the basal-prandial regimen 40.2% were treated with insulin analog and 59.8% with regular insulin. Mean A1C levels were 8.l ± 1.8 and 26.2% had A1C levels